Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.

In this systematic overview, we categorised the efficacy for six comparisons based on information about the effectiveness and safety of intravitreal VEGF inhibitors aflibercept, bevacizumab, and ranibizumab, and each of these intravitreal VEGF inhibitors plus laser therapy.